Jiang Y - Search Results

1

SHP-2-Mediated Upregulation of ZEB1 Is Important for PDGF-B-Induced Cell Proliferation and Metastatic Phenotype in Triple Negative Breast Cancer.

Zhang L, Yuan C, Peng J, Zhou L, Jiang Y, Lin Y, Yin W, Xu S, Ma J, Lu J. Zhang L, et al. Among authors: jiang y. Front Oncol. 2020 Aug 6;10:1230. doi: 10.3389/fonc.2020.01230. eCollection 2020. Front Oncol. 2020. PMID: 32850368 Free PMC article.

2

The prognostic role of cancer stem cells in breast cancer: a meta-analysis of published literatures.

Zhou L, Jiang Y, Yan T, Di G, Shen Z, Shao Z, Lu J. Zhou L, et al. Among authors: jiang y. Breast Cancer Res Treat. 2010 Aug;122(3):795-801. doi: 10.1007/s10549-010-0999-4. Epub 2010 Jun 23. Breast Cancer Res Treat. 2010. PMID: 20571867

3

Prognostic and predictive value of TFF1 for adjuvant endocrine therapy in Chinese women with early ER positive breast cancer: comparing aromatase inhibitors with tamoxifen.

Zhou L, Yan T, Jiang Y, Di G, Shen Z, Shao Z, Lu J. Zhou L, et al. Among authors: jiang y. Breast. 2011 Feb;20(1):15-20. doi: 10.1016/j.breast.2010.06.002. Epub 2010 Jul 8. Breast. 2011. PMID: 20619646 Free article.

4

Association of sulfotransferase SULT1A1 with breast cancer risk: a meta-analysis of case-control studies with subgroups of ethnic and menopausal statue.

Jiang Y, Zhou L, Yan T, Shen Z, Shao Z, Lu J. Jiang Y, et al. J Exp Clin Cancer Res. 2010 Jul 21;29(1):101. doi: 10.1186/1756-9966-29-101. J Exp Clin Cancer Res. 2010. PMID: 20663177 Free PMC article.

5

Postoperative fever: the potential relationship with prognosis in node negative breast cancer patients.

Yan T, Yin W, Zhou L, Jiang Y, Shen Z, Shao Z, Lu J. Yan T, et al. Among authors: jiang y. PLoS One. 2010 Dec 29;5(12):e15903. doi: 10.1371/journal.pone.0015903. PLoS One. 2010. PMID: 21209958 Free PMC article.

6

Trastuzumab in the adjuvant treatment of HER2-positive early breast cancer patients: a meta-analysis of published randomized controlled trials.

Yin W, Jiang Y, Shen Z, Shao Z, Lu J. Yin W, et al. Among authors: jiang y. PLoS One. 2011;6(6):e21030. doi: 10.1371/journal.pone.0021030. Epub 2011 Jun 9. PLoS One. 2011. PMID: 21695277 Free PMC article.

7

The efficacy of zoledronic acid in breast cancer adjuvant therapy: a meta-analysis of randomised controlled trials.

Yan T, Yin W, Zhou Q, Zhou L, Jiang Y, Du Y, Shao Z, Lu J. Yan T, et al. Among authors: jiang y. Eur J Cancer. 2012 Jan;48(2):187-95. doi: 10.1016/j.ejca.2011.10.021. Epub 2011 Nov 17. Eur J Cancer. 2012. PMID: 22100904 Review.

8

First efficacy results of capecitabine with anthracycline- and taxane-based adjuvant therapy in high-risk early breast cancer: a meta-analysis.

Jiang Y, Yin W, Zhou L, Yan T, Zhou Q, Du Y, Shen Z, Shao Z, Lu J. Jiang Y, et al. PLoS One. 2012;7(3):e32474. doi: 10.1371/journal.pone.0032474. Epub 2012 Mar 2. PLoS One. 2012. PMID: 22396769 Free PMC article.

9

Association of alpha2a and beta2 adrenoceptor expression with clinical outcome in breast cancer.

Du Y, Zhou L, Wang Y, Yan T, Jiang Y, Shao Z, Yin W, Lu J. Du Y, et al. Among authors: jiang y. Curr Med Res Opin. 2014 Jul;30(7):1337-44. doi: 10.1185/03007995.2014.890928. Epub 2014 Mar 21. Curr Med Res Opin. 2014. PMID: 24559182

10

Single-nucleotide polymorphism in microRNA-binding site of SULF1 target gene as a protective factor against the susceptibility to breast cancer: a case-control study.

Zhou Q, Jiang Y, Yin W, Wang Y, Lu J. Zhou Q, et al. Among authors: jiang y. Onco Targets Ther. 2016 May 9;9:2749-57. doi: 10.2147/OTT.S102433. eCollection 2016. Onco Targets Ther. 2016. PMID: 27274271 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44,121 results

Search Page

Filters